Move from lead to account, deal, quote, order, invoice and payment with a connected commercial record.
CRM by myLabDesk · Version 15
Run sales with clarity. Grow with intelligence.
Bring relationships, opportunities, follow-ups and commercial workflow into one controlled sales workspace—then turn the same facts into actionable analytics and recommendations.
Private workspace · role-aware access · controlled business data
Territory command centerYear to date
Revenue₹81.5kOn target
Pipeline₹83.6kWeighted view
Follow-ups12Actionable
Qualified pipeline₹58kSupplier performanceOn track
Every sales motion, connected.
Designed for the work that happens before, during and after a customer conversation—not just for storing records.
Prioritize follow-ups, reveal deal risk and focus effort on the relationships that need attention.
Bring contacts, activities, plans, cases and customer health into a clear account view.
Understand product categories, represented suppliers and commercial contribution together.
Turn weighted pipeline and current revenue into a more reliable territory conversation.
Build targeted audiences, campaigns, templates and measured follow-up from CRM context.
Use sequences and controlled workflows to keep important customer moments moving.
Surface next-best actions, account recommendations and explainable insight from authorized data.
Interactive intelligencePower-BI-style analytics Biotech-ready context
More than a conventional CRM.
Explore revenue, targets, pipeline, forecast, supplier performance, product performance and customer insight through shared, drillable analytical context.
Decision dashboards unite KPI cards, trends, commercial funnel, receivables and territory views without separating the data from daily work.
Research-interest mapping, product and supplier intelligence, institution profiling and customer discovery support complex scientific sales.
Start with the right workspace.
Plans and access are controlled by your administrator. Request CRM access or review available options without relying on unverified public pricing.